Skip to main content

Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions

Buy Article:

$55.00 plus tax (Refund Policy)

Epoxyeicosanoids, including the epoxyeicosatrienoic acids, are signaling molecules which appear to help ameliorate the effects of a wide variety of pathological conditions. The enzyme soluble epoxide hydrolase (sEH) metabolizes these molecules by converting them to their corresponding vicinal diols. Inhibition of sEH either by knockout or chemical inhibitors increases epoxyeicosanoid levels in vivo and provides significant organ protection in models of brain, cardiac, and renal injury. sEH also appears to be involved in modulating inflammation, pain pathways, pulmonary function, hypertension, and diabetes. Potent sEH inhibitors have been developed in academic, pharmaceutical, and biotech laboratories and described in the patent and scientific literature. Most of the inhibitor scaffolds employ a urea or amide which functions as an active-site transition state mimic. Arete Therapeutics compound AR9281 successfully completed phase Ia and Ib studies. A phase IIa proof of concept trial for treatment of impaired glucose tolerance has been completed, but the results are not yet reported.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: AR9281; BOEHRINGER INGELHEIM; BTP2; EPHX2; Epoxyeicosanoids; HAMMOCK LABORATORY PHARMACOPHORE MODEL; HOFFMAN LA ROCHE; MCAO (Middle Cerebral; MERCK; Multiple Pathologic Conditions; TAISHO; adamantane piperidinyl ureas; alcohol; alkyl spacers; am-ide; ameliorate; benzoheterocycle; carbamate; cytosol; eicosanoids; endothelial-derived hyperpolarizing factor; epoxyeicosatrienoic acid; farnesyl; geranyl-geranyl; homodimeric bifunctional enzyme; ketone; linoleic acid; piperidinyl ureas; pyrophosphates; sEH; secondary pharmacophore; soluble epoxide hydrolase; transient ischemic attack (TIA); vicinal diols

Document Type: Research Article

Publication date: 2011-02-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more